Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03766347 · ClinicalTrials.gov registry record
Pediatric NMOSD Observational Study
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 100
- Enrollment target
NCT03766347: Completed study, sponsored by Mayo Clinic.
NCT03766347 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03766347 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This study is being done to develop a database of pediatric patients in order to study the cause, early detection and best treatment for neuromyelitis optica spectrum disorder (NMOSD) in pediatric patients.
Primary Outcome
Relapse events of NMOSD defined by clinical worsening of neurological symptoms and treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2024-04-03 |
What the finished NCT03766347 record still lists
NCT03766347 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03766347 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03766347 about?
NCT03766347 is a clinical study titled "Pediatric NMOSD Observational Study". This study is being done to develop a database of pediatric patients in order to study the cause, early detection and best treatment for neuromyelitis optica spectrum disorder (NMOSD) in pediatric patients.
What is the current status of trial NCT03766347?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2018-02-01. Estimated completion is 2024-04-03.
Who is sponsoring clinical trial NCT03766347?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI